Dr. John Penta was for 25 years, a section of Chief of the National Cancer Institute, National Institutes of Health (NIH).
In addition, he was Adjunct Associate Professor of Medicine in the Department of Medicine Division of Medical Oncology at Duke University of School of Medicine.
Dr. Penta was involved in clinical research studies evaluating experimental treatments in very sick cancer patients who has short life expectancy and in whom conventional treatment options were exhausted. He was part of national team that developed an active chemotherapy regimen for osteogenic sarcoma in children and young adults in the late 70’s.
Read more at eastboston.com
